Metraipolis › archive › dc_6b719ce554da
Development and Validation of a Machine Learning Model to Predict Anti-Drug Antibody Formation During Infliximab Induction in Crohn's Disease — Europe PMC PMID:41153747
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41153747
- DOI
- 10.3390/biomedicines13102464
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T10:16:20.046Z
- SHA-256 of the archived text
fe440fa322677b6ac5913641abf83d54ff725c686a5ea4b94b004975db1a9787- Stable URL of this page
https://metraipolis.com/documento/dc_6b719ce554da
How to cite
Development and Validation of a Machine Learning Model to Predict Anti-Drug Antibody Formation During Infliximab Induction in Crohn's Disease — Europe PMC PMID:41153747 — Europe PMC (en), https://europepmc.org/article/MED/41153747 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6b719ce554da (Metraipolis archive dc_6b719ce554da, sha256 fe440fa322677b6ac5913641abf83d54ff725c686a5ea4b94b004975db1a9787)
BibTeX
@misc{dc6b719ce554da,
title = {Development and Validation of a Machine Learning Model to Predict Anti-Drug Antibody Formation During Infliximab Induction in Crohn's Disease — Europe PMC PMID:41153747},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41153747},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6b719ce554da; sha256 fe440fa322677b6ac5913641abf83d54ff725c686a5ea4b94b004975db1a9787},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41153747. Agents can read the archived copy with the MCP tool read_document.